Towards artificial metallonucleases for gene therapy: Recent advances and new perspectives

Béla Gyurcsik, Anikó Czene

Research output: Contribution to journalReview article

17 Citations (Scopus)


The process of DNA targeting or repair of mutated genes within the cell, induced by specifically positioned double-strand cleavage of DNA near the mutated sequence, can be applied for gene therapy of monogenic diseases. For this purpose, highly specific artificial metallonucleases are developed. They are expected to be important future tools of modern genetics. The present state of art and strategies of research are summarized, including protein engineering and artificial 'chemical' nucleases. From the results, we learn about the basic role of the metal ions and the various ligands, and about the DNA binding and cleavage mechanism. The results collected provide useful guidance for engineering highly controlled enzymes for use in gene therapy.

Original languageEnglish
Pages (from-to)1935-1966
Number of pages32
JournalFuture Medicinal Chemistry
Issue number15
Publication statusPublished - Nov 1 2011

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Towards artificial metallonucleases for gene therapy: Recent advances and new perspectives'. Together they form a unique fingerprint.

  • Cite this